A special edition of the Health Care Digest during the ongoing 37th annual J.P. Morgan Healthcare Conference going on in San Francisco. Aimmune Therapeutics Inc. CEO Jayson Dallas started his presentation Monday at the 37th annual J.P. Morgan Healthcare Conference describing the company as "a 2019 story." That may be more true than even Dallas knows. The Brisbane company (NASDAQ: AIMT) is on the cusp of a breakthrough in th e treatment of peanut allergy. It looks to win Food and Drug Administration… (Source: bizjournals.com Health Care:Biotechnology headlines)
MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader http://bit.ly/2RFggJC
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.